Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Oct 27;289(6452):1097–1100. doi: 10.1136/bmj.289.6452.1097

Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma.

E M Rankin, A Hekman, M R Hardeman, C A Hoefnagel
PMCID: PMC1443296  PMID: 6435791

Abstract

The migration pattern of lymphocytes labelled with indium-111 was followed in a patient with B cell non-Hodgkin's lymphoma treated with a murine monoclonal anti-idiotype antibody. During the early phase of continuous infusion of antibody rapid fluxes of labelled lymphocytes into and out of the blood were seen. Dynamic scanning showed immediate uptake in the lungs; thereafter activity decreased in the lungs and increased in the liver. Studies of labelled and unlabelled cells in the circulation showed that treatment resulted in the removal of lymphocytes from the blood which was repopulated from an extravascular compartment. Tumour cells were shown to be cleared from the blood by the reticuloendothelial system in the liver. Indium-111 should be used circumspectly because it may cause chromosomal damage in labelled cells, but it is clearly useful as a radiolabel for following the migration pathways of lymphocytes in vivo.

Full text

PDF
1097

Images in this article

1099FIG 4
on p.1099
1099FIG 5
on p.1099
1099FIG 6
on p.1099

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball E. D., Bernier G. M., Cornwell G. G., 3rd, McIntyre O. R., O'Donnell J. F., Fanger M. W. Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. Blood. 1983 Dec;62(6):1203–1210. [PubMed] [Google Scholar]
  2. Dillman R. O., Shawler D. L., Sobol R. E., Collins H. A., Beauregard J. C., Wormsley S. B., Royston I. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia. Blood. 1982 May;59(5):1036–1045. [PubMed] [Google Scholar]
  3. Hamblin T. J., Abdul-Ahad A. K., Gordon J., Stevenson F. K., Stevenson G. T. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer. 1980 Oct;42(4):495–502. doi: 10.1038/bjc.1980.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lavender J. P., Goldman J. M., Arnot R. N., Thakur M. L. Kinetics of indium-III labelled lymphocytes in normal subjects and patients with Hodgkin's disease. Br Med J. 1977 Sep 24;2(6090):797–799. doi: 10.1136/bmj.2.6090.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Manaster J., Frühling J., Stryckmans P. Kinetics of lymphocytes in chronic lymphocytic leukemia. I. Equilibrium between blood and a "readily accessible pool". Blood. 1973 Mar;41(3):425–438. [PubMed] [Google Scholar]
  6. Miller R. A., Maloney D. G., McKillop J., Levy R. In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood. 1981 Jul;58(1):78–86. [PubMed] [Google Scholar]
  7. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  8. Miller R. A., Oseroff A. R., Stratte P. T., Levy R. Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood. 1983 Nov;62(5):988–995. [PubMed] [Google Scholar]
  9. Nadler L. M., Stashenko P., Hardy R., Kaplan W. D., Button L. N., Kufe D. W., Antman K. H., Schlossman S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep;40(9):3147–3154. [PubMed] [Google Scholar]
  10. Scott J. L., McMillan R., Marino J. V., Davidson J. G. Leukocyte labeling with 51 chromium. IV. The kinetics of chronic lymphocytic leukemic lymphocytes. Blood. 1973 Jan;41(1):155–162. [PubMed] [Google Scholar]
  11. Stevenson G. T., Stevenson F. K. Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature. 1975 Apr 24;254(5502):714–716. doi: 10.1038/254714a0. [DOI] [PubMed] [Google Scholar]
  12. Themi H., Trepel F., Schick P., Kaboth W., Begemann H. Kinetics of lymphocytes in chronic lymphocytic leukemia: studies using continuous 3H-thymidine infusion in two patients. Blood. 1973 Oct;42(4):623–636. [PubMed] [Google Scholar]
  13. Wagstaff J., Gibson C., Thatcher N., Crowther D. The migratory properties of indium-111 oxine labelled lymphocytes in patients with chronic lymphocytic leukaemia. Br J Haematol. 1981 Oct;49(2):283–291. doi: 10.1111/j.1365-2141.1981.tb07225.x. [DOI] [PubMed] [Google Scholar]
  14. Wagstaff J., Gibson C., Thatcher N., Ford W. L., Sharma H., Benson W., Crowther D. A method for following human lymphocyte traffic using indium-111 oxine labelling. Clin Exp Immunol. 1981 Mar;43(3):435–442. [PMC free article] [PubMed] [Google Scholar]
  15. Wagstaff J., Gibson C., Thatcher N., Ford W. L., Sharma H., Crowther D. Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations. Clin Exp Immunol. 1981 Mar;43(3):443–449. [PMC free article] [PubMed] [Google Scholar]
  16. Zimmerman T. S., Godwin H. A., Perry S. Studies of leukocyte kinetics in chronic lymphocytic leukemia. Blood. 1968 Mar;31(3):277–291. [PubMed] [Google Scholar]
  17. ten Berge R. J., Natarajan A. T., Hardeman M. R., van Royen E. A., Schellekens P. T. Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication. J Nucl Med. 1983 Jul;24(7):615–620. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES